Clinical Trials

Breast Neoplasms, Breast Neoplasms, Male

NCT07158021 2026-02-13

Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial

Phase 2 Recruiting

75 enrolled

Phase 3 Active not recruiting

Breast Neoplasms

NCT01674140 2026-02-10

e3

1,939 enrolled 15 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT03056755 2026-01-13

BYLieve

383 enrolled 16 charts

Breast Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT05122377 2026-01-06

RWE About QOL and Compliance of Patients With OFS in China

562 enrolled

Breast Neoplasms, Patient Compliance

NCT07159451 2025-12-01

POP-ELA

Phase 2 Recruiting

140 enrolled

Breast Neoplasms

NCT04569747 2025-11-13

ADEPT

Phase 2 Recruiting

375 enrolled

Phase 2 Not yet recruiting

Breast Neoplasms

NCT07179939 2025-09-18

Maintenance Therapy in HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer: A Phase II Study

288 enrolled

Phase 2 Active not recruiting

HER2-positive Breast Cancer

NCT03900637 2024-07-31

PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS Rate

122 enrolled

Phase 3 Active not recruiting

Breast Neoplasms

NCT02344472 2024-06-04

Detect V / CHEVENDO (Chemo vs. Endo)

271 enrolled

Breast Neoplasms

NCT03272477 2024-04-17

TP-II

257 enrolled

Breast Neoplasms

NCT03664895 2023-12-04

Density Lowering Effect of "OFS Add on to TMX"(DELFINO Trial)

Phase 3 Unknown

224 enrolled

Breast Cancer Invasive

NCT02941926 2023-10-24

COMPLEEMENT-1

Phase 3 Completed

3,246 enrolled 11 charts

Breast Neoplasms

NCT02990845 2023-02-22

PEER

Phase 1/2 Terminated

16 enrolled

Premenopausal Breast Cancer

NCT02914158 2023-01-17

ASPAIT

Phase 3 Unknown

680 enrolled

Breast Neoplasms

NCT01989780 2022-08-04

BOOSTER

160 enrolled

Breast Neoplasms

NCT02344550 2020-07-30

LEO

137 enrolled

Breast Neoplasms

NCT03209518 2019-11-01

Special Drug Use Surveillance of Leuprorelin for Injection Kit 22.5 mg in "Premenopausal Breast Cancer"

312 enrolled 17 charts

Premenopausal Breast Cancer

NCT02592746 2019-04-08

A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC

Phase 2 Unknown

182 enrolled

Breast Neoplasms

NCT02689921 2018-09-28

NEOADAPT

Phase 2 Unknown

7 enrolled

Breast Neoplasms

NCT03497702 2018-04-13

NeoChAI

Phase 2 Unknown

114 enrolled

Breast Neoplasms

NCT02980965 2017-11-13

Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast Cancer

Phase 3 Completed

249 enrolled

Breast Neoplasms

NCT02134977 2016-10-18

Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey: "QOL Survey in Premenopausal Breast Cancer Patients"

2,816 enrolled 29 charts

Breast Neoplasms

NCT00903162 2016-04-18

Extended Endocrine Therapy for Premenopausal Women With Breast Cancer

17 enrolled 5 charts

Breast Neoplasms

NCT02154139 2016-02-17

Leuprorelin Acetate SR 11.25 mg for Injection Specified Drug-use Survey "Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)"

651 enrolled 12 charts

Breast Neoplasms

NCT00002580 2013-11-06

Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer

Phase 3 Completed

1,000 enrolled

Breast Neoplasms

NCT00498901 2013-05-09

Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer

Phase 2 Terminated

1 enrolled